James C. Lin

Davis Polk advised the placement facilitation agents in connection with the placement outside of Mexico of Ps. 1 billion aggregate principal amount of the 7.930% Certificados Bursátiles due…

Davis Polk advised the underwriter in connection with a secondary offering of 12,000,000 American Depositary Shares of Hutchison China Meditech Limited (“Chi-Med”), each representing five…

Davis Polk advised the underwriters in connection with the SEC-registered Schedule B debt offerings by the Export-Import Bank of Korea (“KEXIM”) of $500 million aggregate principal amount…

Davis Polk advised the initial purchasers in connection with a Rule 144A and Regulation S offering by YY Inc. (NASDAQ: YY) of $425 million aggregate principal amount of 0.750% convertible…

Davis Polk advised Tencent Holdings Limited as English and U.S. law counsel in connection with the upsize and update of its $20 billion global medium-term note program and the offering…

Davis Polk advised the initial purchasers in connection with a Rule 144A and Regulation S offering by iQIYI, Inc. of $1.2 billion aggregate principal amount of its 2.00% convertible senior…

Davis Polk advised the representatives of the underwriters on the SEC-registered initial public offering by UP Fintech Holding Limited (Tiger Trade) of 13,000,000 American Depositary Shares…

Davis Polk advised the representatives of the underwriters in the offering of 69,000,000 American Depositary Shares by Sea Limited for total proceeds of over $1.5 billion, including the…

Davis Polk advised the joint lead managers on a Rule 144A/Regulation S offering by SP Group Treasury Pte. Ltd. of $600 million aggregate principal amount of 3.375% notes due 2029 under its…

Davis Polk advised CStone Pharmaceuticals in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule 144A…